Retinoids in the Pathogenesis and Treatment of Liver Diseases

Overview

Journal Nutrients

Date 2022 Apr 12

PMID 35406069

Authors

Marta Melis

Xiao-Han Tang

Steven E Trasino

Lorraine J Gudas

Affiliations

Soon will be listed here.

Abstract

Vitamin A (VA), all-trans-retinol (ROL), and its analogs are collectively called retinoids. Acting through the retinoic acid receptors RARα, RARβ, and RARγ, all-trans-retinoic acid, an active metabolite of VA, is a potent regulator of numerous biological pathways, including embryonic and somatic cellular differentiation, immune functions, and energy metabolism. The liver is the primary organ for retinoid storage and metabolism in humans. For reasons that remain incompletely understood, a body of evidence shows that reductions in liver retinoids, aberrant retinoid metabolism, and reductions in RAR signaling are implicated in numerous diseases of the liver, including hepatocellular carcinoma, non-alcohol-associated fatty liver diseases, and alcohol-associated liver diseases. Conversely, restoration of retinoid signaling, pharmacological treatments with natural and synthetic retinoids, and newer agonists for specific RARs show promising benefits for treatment of a number of these liver diseases. Here we provide a comprehensive review of the literature demonstrating a role for retinoids in limiting the pathogenesis of these diseases and in the treatment of liver diseases.

Citing Articles

C6orf120 Deficiency Inhibits Hepatic Stellate Cell Activation by Upregulating RARβ Signaling.

Lin Y, Wang X, Cui X, Zhu N, Li Y, Li X Cell Biochem Biophys. 2025; .

PMID: 39904869 DOI: 10.1007/s12013-025-01682-w.

The role and function of lncRNA in ageing-associated liver diseases.

Zarandi P, Ghiasi M, Heiat M RNA Biol. 2024; 22(1):1-8.

PMID: 39697114 PMC: 11660375. DOI: 10.1080/15476286.2024.2440678.

Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression.

Forte E, Sanders J, Pla I, Kanchustambham V, Hollas M, Huang C Mol Cell Proteomics. 2024; 23(12):100876.

PMID: 39521382 PMC: 11664408. DOI: 10.1016/j.mcpro.2024.100876.

IL-22 resolves MASLD via enterocyte STAT3 restoration of diet-perturbed intestinal homeostasis.

Zhang P, Liu J, Lee A, Tsaur I, Ohira M, Duong V Cell Metab. 2024; 36(10):2341-2354.e6.

PMID: 39317186 PMC: 11631175. DOI: 10.1016/j.cmet.2024.08.012.

Immunogenomic profiles and therapeutic options of the pan-programmed cell death-related lncRNA signature for patients with bladder cancer.

Yang J, Zhang L, Zhu B, Wu H, Peng M Sci Rep. 2024; 14(1):18500.

PMID: 39122807 PMC: 11316077. DOI: 10.1038/s41598-024-68859-w.

References

Bitetto D, Bortolotti N, Falleti E, Vescovo S, Fabris C, Fattovich G . Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy. Hepatology. 2012; 57(3):925-33. DOI: 10.1002/hep.26186. View

Kisseleva T, Brenner D . Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol. 2020; 18(3):151-166. DOI: 10.1038/s41575-020-00372-7. View

Ganne-Carrie N, Nahon P . Hepatocellular carcinoma in the setting of alcohol-related liver disease. J Hepatol. 2019; 70(2):284-293. DOI: 10.1016/j.jhep.2018.10.008. View

Celli R, Zhang X . Pathology of Alcoholic Liver Disease. J Clin Transl Hepatol. 2015; 2(2):103-9. PMC: 4521259. DOI: 10.14218/JCTH.2014.00010. View

Gudas L, Wagner J . Retinoids regulate stem cell differentiation. J Cell Physiol. 2010; 226(2):322-30. PMC: 3315372. DOI: 10.1002/jcp.22417. View

Jeong W, Park O, Radaeva S, Gao B . STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. Hepatology. 2006; 44(6):1441-51. DOI: 10.1002/hep.21419. View

Vasiliou V, Pappa A, Estey T . Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism. Drug Metab Rev. 2004; 36(2):279-99. DOI: 10.1081/dmr-120034001. View

Shackel N, Warner F . Identification of resident hepatic stem cell populations. Hepatology. 2007; 46(6):2042-4. DOI: 10.1002/hep.22091. View

Zhang X, Xu C, Yu C, Chen W, Li Y . Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2014; 20(7):1768-76. PMC: 3930975. DOI: 10.3748/wjg.v20.i7.1768. View

10.

Napoli J . Effects of ethanol on physiological retinoic acid levels. IUBMB Life. 2011; 63(9):701-6. PMC: 3197900. DOI: 10.1002/iub.500. View

11.

Lee Y, Jeong W . Retinoic acids and hepatic stellate cells in liver disease. J Gastroenterol Hepatol. 2012; 27 Suppl 2:75-9. DOI: 10.1111/j.1440-1746.2011.07007.x. View

12.

Langton S, Gudas L . CYP26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid. Dev Biol. 2008; 315(2):331-54. DOI: 10.1016/j.ydbio.2007.12.021. View

13.

Cooper J, Reynolds C, Cho H, Kang M . Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives. Exp Biol Med (Maywood). 2017; 242(11):1178-1184. PMC: 5478002. DOI: 10.1177/1535370217706952. View

14.

Sabichi A, Xu H, Fischer S, Zou C, Yang X, Steele V . Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites. Clin Cancer Res. 2003; 9(12):4606-13. View

15.

Tang X, Melis M, Lu C, Rappa A, Zhang T, Jessurun J . A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease. J Biol Chem. 2021; 297(6):101331. PMC: 8626588. DOI: 10.1016/j.jbc.2021.101331. View

16.

Melis M, Tang X, Trasino S, Patel V, Stummer D, Jessurun J . Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease. PLoS One. 2019; 14(1):e0211071. PMC: 6345457. DOI: 10.1371/journal.pone.0211071. View

17.

Okada H, Honda M, Campbell J, Sakai Y, Yamashita T, Takebuchi Y . Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development. Cancer Res. 2012; 72(17):4459-71. DOI: 10.1158/0008-5472.CAN-12-0028. View

18.

Park E, Lau A, Arendt K, Chen L . FMRP Interacts with RARα in Synaptic Retinoic Acid Signaling and Homeostatic Synaptic Plasticity. Int J Mol Sci. 2021; 22(12). PMC: 8235556. DOI: 10.3390/ijms22126579. View

19.

Zhang L, Huang D, Shao D, Liu H, Zhou Q, Gui S . Fenretinide inhibits the proliferation and migration of human liver cancer HepG2 cells by downregulating the activation of myosin light chain kinase through the p38‑MAPK signaling pathway. Oncol Rep. 2018; 40(1):518-526. DOI: 10.3892/or.2018.6436. View

20.

Younossi Z, Stepanova M, Ong J, Jacobson I, Bugianesi E, Duseja A . Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. Clin Gastroenterol Hepatol. 2018; 17(4):748-755.e3. DOI: 10.1016/j.cgh.2018.05.057. View